Budelin Novolizer 200 mikrograma/dozi prašak inhalata
| Name | Budelin Novolizer 200 mikrograma/dozi prašak inhalata |
|---|---|
| Former Name | Tafen Novolizer 200 µg prašak za inhaliranje |
| Marketing Authorisation Number | HR-H-730386222 |
| Active Substance | budezonid |
| Composition | jedna inhalacijska doza sadržava 200 mikrograma budezonida |
| Pharmaceutical Form | prašak inhalata |
| Manufacturer | McDermott Laboratories Limited, t/a Mylan Dublin Respiratory, Dublin 13, Irska A&M Stabtest GmbH, Mainz, Njemačka |
| Marketing Authorisation Holder | Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.01.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/13-02/471 |
| Registration Number | 381-12-01/30-18-27 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03BA02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
